Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory…
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
